<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"cancer mortality":1,
"hepatoma":1,
"hyperinsulinemia":1,
"pancreatic cancer":1,
"Gestational trophoblastic disease":1,
"Grossesse molaire":1,
"Hormone chorionique gonadotrophique":1,
"Human gonadotrophin chorinic":1,
"Hyperthyroidism":2,
"Hyperthyroïdie":1,
"Maladie gestationnelle trophoblastique":1,
"Molar pregnancy":1,
"Sialysation":1,
"Thyrotoxicose":1,
"Thyrotoxicosis":1,
"chemotherapy":1,
"cisplatin":1,
"intra-arterial chemotherapy":1,
"laryngeal cancer":1,
"neoadjuvant":1,
"capsular invasion":1,
"papillary thyroid carcinoma":13,
"radioactive iodine ablation":1,
"recurrence":3,
"Lymphoma":1,
"Multidetector computed tomography":1,
"Thyroid gland":1,
"Ultrasonography":4,
"CROHN'S DISEASE":1,
"GENETICS":1,
"IBD - GENETICS":1,
"INFLAMMATION":1,
"Multiple functions":1,
"NR4A":1,
"Novel ligands":1,
"Nuclear receptors":1,
"elastography":1,
"malignant":1,
"nodule":2,
"thyroid":11,
"ultrasound":4,
"3&nbsp":1,
"T Magnetic Resonance Imaging":1,
"IDEAL sequences":1,
"Parathyroid adenoma":1,
"Presurgical localisation":1,
"Primary hyperparathyroidism":1,
"Anabolic hormones":1,
"Hormones anabolisantes":1,
"Prolactinoma":1,
"Prolactinome":1,
"Thyroid volume":1,
"Volume thyroïdien":1,
"Breast cancer":3,
"Clinicopathology":1,
"MicroRNA-200":1,
"Real-time quantitative PCR":1,
"18F-FDG PET/CT":1,
"Differentiated thyroid carcinoma":2,
"High/intermediate-risk thyroid carcinoma":1,
"Therapeutic management":1,
"ACTH = adrenocorticotropic hormone":1,
"FSH = follicle-stimulating hormone":1,
"GH = growth hormone":1,
"GnRH = gonadotropin-releasing hormone":1,
"IGF-1= insulin-like growth factor-1":1,
"LH = luteinizing hormone":1,
"NFA = nonfunctional adenoma":1,
"T4 = thyroxine":1,
"TRH = thyrotropin-releasing hormone":1,
"TSH = thyroid-stimulating hormone":1,
"endocrine deficits":1,
"hypopituitarism":1,
"nonfunctional adenoma":1,
"pituitary surgery":1,
"Biopsy":2,
"Diagnosis":3,
"Fine needle aspiration":4,
"Population-based cohort":1,
"Thyroid cancer":22,
"Thyroid ultrasound":1,
"Radioiodine":2,
"Thyroglobulin":4,
"Thyroid ablation":1,
"rhTSH":1,
"18F-FDG-PET/CT":1,
"paraneoplastic cerebellar degeneration":1,
"paraneoplastic neurological syndrome (PNS)":1,
"Carcinoma del quiste":1,
"Cyst carcinoma":1,
"Quiste tirogloso":1,
"Sistrunk":1,
"Thyroglossal cyst":1,
"Thyroidectomy":4,
"Tiroidectomía":1,
"EMT":1,
"NF-κB":1,
"PTC":1,
"Twist1":1,
"Differential diagnosis":1,
"Immunohistochemistry":5,
"Neck mass":1,
"Spindle epithelial tumor with thymus-like differentiation (SETTLE)":1,
"Therapy":1,
"Tumor of the thyroid gland":1,
"Hypocalcemia":1,
"Parathyroid glands":1,
"anaplastic thyroid carcinoma":2,
"cutaneous metastases":1,
"spindle cells":1,
"BRAF":2,
"RET- PTC":1,
"TERT":1,
"pediatric thyroid carcinoma":1,
"thyroid carcinoma":5,
"ETV6/NTRK3":1,
"gene fusions":1,
"molecular diagnostics":1,
"molecular pathology":1,
"pediatric":2,
"thyroid neoplasms":8,
"demographic":1,
"endocrine cancer":1,
"parathyroid cancer":1,
"parathyroidectomy":1,
"patient community":1,
"patient environment":1,
"surgeon volume":1,
"fetal development":1,
"mothers":1,
"pregnancy":1,
"risk factors":2,
"fine-needle aspiration biopsy":2,
"lymph nodes":2,
"metastasis":3,
"predictive model":1,
"Ephrin receptor":1,
"genome-wide":1,
"oncogenic gene signature":1,
"tumor progression":1,
"tumor suppressor":1,
"SSc":1,
"thyroid autoimmunity":1,
"thyroid nodules":2,
"Cell proliferation":1,
"Polycomb enhancer of zeste homolog 2 (EZH2)":1,
"Thyroid-stimulating hormone receptor (TSHR)":1,
"lncRNA PVT1":1,
"Metastatic lung carcinoma":1,
"Napsin A":1,
"PAX8":1,
"Primary lung carcinoma":1,
"TTF-1":1,
"gender":1,
"radiation exposure":1,
"survival":3,
"well-differentiated thyroid cancer":1,
"Extrathyroidal extension":3,
"p16":1,
"p27":1,
"p53":1,
"Ribonucleotide reductase large subunit M1":1,
"Undifferentiated thyroid carcinoma":2,
"Langerhans cells":1,
"cutaneous metastasis":2,
"oncology":1,
"Asistencia sanitaria integral":1,
"Comprehensive health care":1,
"Consenso":1,
"Consensus":1,
"Cáncer de tiroides":1,
"Equipo multidisciplinar":1,
"Flujo de pacientes":1,
"Multidisciplinary team":1,
"Organización":1,
"Organization":1,
"Patient flow":1,
"Requirements":1,
"Requisitos":1,
"Biomarker":3,
"Gastric cancer":1,
"Plasma":1,
"miR-940":1,
"Bethesda":1,
"atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS)":1,
"fine-needle aspiration (FNA)":1,
"follicular variant":2,
"noninvasive":1,
"noninvasive follicular thyroid (NIFT)":1,
"AKT3":1,
"Proliferation":2,
"miR-29a":1,
"Invasion":2,
"PKM2":1,
"Pancreatic ductal adenocarcinoma":1,
"Warburg effect":1,
"Children":1,
"Fine-needle aspiration":1,
"Malignancy":2,
"(131)I":1,
"Cáncer diferenciado de tiroides":1,
"Dosimetría individualizada":1,
"Individualised dosimetry":1,
"Metabolic therapy":1,
"Terapia metabólica":1,
"Mesenchymal neoplasm":1,
"Schwannoma":1,
"Graves' disease":1,
"Surgery":2,
"Carcinoma":1,
"LKB1":1,
"Mutation":2,
"STK11":1,
"Adrenal metastasis":1,
"Liver metastasis":1,
"Pancreatic metastasis":1,
"Renal metastasis":1,
"Lymphatic Metastasis":1,
"Pathology":1,
"median household income":1,
"socioeconomic status":1,
"well differentiated thyroid cancer":1,
"Telomerase":1,
"Thyroid cancer, papillary":3,
"circulating epithelial cells":1,
"differentiated thyroid cancer":2,
"lymph node washout":1,
"PARP4":1,
"breast":1,
"cancer":2,
"germline mutation":1,
"bevacizumab":1,
"locally advanced":1,
"neoadjuvant chemotherapy":1,
"nonsmall cell lung cancer":1,
"Three-dimensional ultrasonography":1,
"Thyroid neoplasm":1,
"Tomographic ultrasound imaging":1,
"Tumor staging":1,
"Lymphadenectomy":1,
"Subtotal/total thyroidectomy":1,
"Bcl-xL":1,
"Nrf2":1,
"Papillary thyroid cancer":3,
"TRAIL":1,
"TRAIL-resistant":1,
"Valproic acid":1,
"BRAF V600E mutation":1,
"TERT promoter mutation":1,
"genetic molecular markers":1,
"prognosis":2,
"telomerase reverse transcriptase":1,
"Myotonic dystrophy type 1":1,
"Thyroid disease":1,
"Tumor":1,
"Pendred syndrome":1,
"TP53":1,
"cervical lymph node":1,
"conventional smear":1,
"fine needle aspiration cytology":1,
"head and neck squamous cell carcinoma":1,
"liquid-based cytology":1,
"Thyroid cancer, follicular":1,
"follow-up studies":1,
"questionnaires":1,
"retinoblastoma":1,
"risk":1,
"survivors":1,
"early detection of cancer":1,
"radioactive hazard release":1,
"BAP1":1,
"Cancer genetics":1,
"melanoma":2,
"tumor predisposition syndrome":1,
"Childhood cancer survivors":1,
"Radiotherapy":1,
"Surveillance":1,
"Donor site":1,
"Immediate reconstruction":1,
"Nipple-sparing mastectomy":1,
"Perforator flap":1,
"Skin-sparing mastectomy":1,
"calcitonin":1,
"medullary thyroid carcinoma":3,
"negative predictive value":1,
"procalcitonin":1,
"Anthropometry":1,
"Cosmesis":1,
"Endocrine surgery":1,
"Follow-up":1,
"Outcomes":1,
"Robotic":1,
"Scar":1,
"Transaxillary":1,
"MAPK genetic alterations":1,
"Sonic Hedgehog pathway":1,
"type 3 deiodinase, papillary thyroid carcinoma":1,
"Ascorbic acid (PubChem CID: 54670067)":1,
"Formulation":1,
"Freeze-Drying":1,
"Gentisic acid (PubChem CID: 3469)":1,
"In-111":1,
"Minigastrin":1,
"Radiopharmaceutical Kit":1,
"Sodium hydroxide (PubChem CID: 14798)":1,
"l-Methionine (PubChem CID: 6137)":1,
"Ciliated muconodular papillary tumor":1,
"Glandular papilloma":1,
"Mucinous adenocarcinoma":1,
"Papillary adenocarcinoma":1,
"Peripheral lung tumor":1,
"Ectopic":1,
"Intrathyroidal":1,
"Thymoma":1,
"Thymus":1,
"thyroid atypia of undetermined significance":1,
"thyroid fine-needle aspiration biopsy":1,
"thyroid follicular lesion of undetermined significance":1,
"Mitochondria":1,
"Sellar neoplasms":1,
"Spindle cell oncocytoma":1,
"In situ hybridization":1,
"MicroRNA":1,
"Non-coding RNA":1,
"lncRNA":1,
"Epidemiology":1,
"Incidence":1,
"Metastatic":1,
"Regional":1,
"Data Reporting":1,
"Head and Neck Neoplasms":1,
"Patient-reported outcome":1,
"Quality of Life [I01 800]":1,
"Systematic Review":1,
"PI-3 kinase":1,
"Snail":1,
"c-Met":1,
"cell motility and invasion":1,
"sonic hedgehog signaling pathway":1,
"Alu repeats":1,
"DNA hypomethylation":1,
"human cancer":1,
"routine clinical biospecimens":1,
"NF1":1,
"TSC1":1,
"everolimus":1,
"mTOR":1,
"next-generation sequencing":1,
"AKT pathway":1,
"RET/PTC":2,
"miR-451a":1,
"miRNA":1,
"Immune-checkpoint inhibitors":1,
"Immune-related adverse events":1,
"Ipilimumab":1,
"Lung cancer":1,
"Nivolumab":1,
"Pembrolizumab":1,
"Renal cancer":1,
"Metabolic syndrome":1,
"Nonalcoholic fatty liver disease":1,
"Obesity":1,
"Type 2 diabetes":1,
"complication":1,
"frequency":1,
"head and neck ultrasound":1,
"risk factor":2,
"thyroid nodule":1,
"AKT":1,
"IGF-1R":1,
"miR-30a":1,
"p53R273H":1,
"ROI":1,
"Young modulus":1,
"elasticity imaging techniques":1,
"follicular thyroid neoplasm":1,
"reliability":1,
"reproducibility":1,
"shear-wave elastography":1,
"SEER":1,
"age":1,
"medullary thyroid cancer":1,
"nomogram":1,
"CCK2R":1,
"CCKBR":1,
"cholecystokinin 2 receptor":1,
"gastrin receptor":1,
"RAS":1,
"WNT signaling":1,
"radiation":1,
"Gerotarget":1,
"elderly patients":1,
"immunocytochemistry":1,
"liquid based cytology":1,
"malignancies":1,
"thyroid lesions":1,
"CUDC-101":1,
"anaplastic thyroid cancer":2,
"apoptosis":1,
"carfilzomib":1,
"combination therapy":1,
"adrenal-associated endocrinopathy":1,
"adrenocortical neoplasm":1,
"aging":1,
"and thyroid":1,
"cysts":1,
"diabetes mellitus":1,
"endocrine tumors":1,
"endocrinopathies":1,
"estrogen-induced anemia":1,
"ferret":1,
"gonadectomy":1,
"insulinoma":1,
"islet cell tumor":1,
"multiple endocrine neoplasia":1,
"neuroblastoma":1,
"ovary":1,
"pancreatic polypeptidoma":1,
"parathyroid":1,
"pheochromocytoma":1,
"pituitary":1,
"review":1,
"teratoma":1,
"testis":1,
"18F-fluorodeoxyglucose":1,
"BRAF mutation":1,
"Positron-emission tomography":1,
"BRAF inhibitor":1,
"MEK inhibitor":1,
"programmed cell death-1":1,
"programmed cell death-ligand 1":1,
"Papillary":2,
"Lymph node dissection":1,
"Lymph node metastases":1,
"First-degree family history":1,
"Bone metastasis":1,
"Bone scintigraphy":1,
"F-18 sodium fluoride":1,
"Positron emission tomography":2,
"Fish consumption":1,
"Lake Ontario":1,
"Omega-3 fatty acids":1,
"Polychlorinated biphenyls":1,
"GWAS":1,
"Inbreeding":1,
"Runs of homozygosity":1,
"I-131":1,
"irradiation":1,
"radiopharmaceuticals":1,
"targeted therapy":1,
"herpesviruses":1,
"polyomaviruses":1,
"HMGA1":1,
"RNA interference":1,
"S100A13":1,
"Adjuvant":1,
"Aromatase inhibitors":1,
"Early breast cancer":1,
"Functional Assessment of Cancer Therapy-Breast":1,
"Hormone receptor-positive early-stage breast cancer postmenopause":1,
"Prospective":1,
"Quality of life":1,
"Trial outcome index":1,
"Bronchopneumonia":1,
"enteritis":1,
"gazelle":1,
"mortality":1,
"trauma":1,
"malignant potential":1,
"tumors":1,
"atherosclerosis":1,
"genome‐wide association study":1,
"non‐coding RNA":1,
"polymorphism":1,
"stroke":1,
"Breast neoplasms":1,
"Cancer screening":1,
"Chronic disease":1,
"Comorbidity":1,
"France":1,
"Uterine cervical neoplasms":1,
"Oncogenic signaling pathway":1,
"Pin1":1,
"Treatment":1,
"Ectopic thyroid cancer":1,
"Local invasion":1,
"Stent":1,
"Substernal":1,
"Trachea relapse":1,
"multiple kinase inhibitor":1,
"progression-free survival":1,
"Notch 1 receptor":1,
"radioiodine remnant ablation":2,
"tumor aggressiveness":1,
"solitary pulmonary metastasis":1,
"surgical resection":1,
"Breast metastasis":1,
"Isolated metastasis":1,
"Papillary carcinoma":1,
"Low-risk thyroid carcinoma":1,
"Neck ultrasound":1,
"Thyroglobulin temporal trend":1,
"Thyroid adenoma":1,
"neoplasm of the endocrine system":1,
"Laryngocele":1,
"laryngeal cyst":1,
"fluorine-18-fluorodeoxyglucose":1,
"goiter":1,
"retropharyngeal":1,
"Nodular Goiter":1,
"medullary carcinoma of thyroid gland":1,
"the same side":1,
"thyroid papillary carcinoma":1,
"cutaneous":1,
"follicular thyroid carcinoma":1,
"lung":1,
"bone":1,
"acute":1,
"laryngeal spasm":1,
"low calcium":1,
"thyroid cancer surgery":1,
"Cytomorphology":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2016年3月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
